Eyal Kalo
Hoofd Techniek/Wetenschap/O&O bij ESENSE-LAB LTD
Profiel
Eyal Kalo is currently the Director of Research & Development at InnoCan Pharma Corp.
and the Chief Technology Officer at eSense-Lab Ltd.
He holds a doctorate degree from the Weizmann Institute of Science, which was conferred in 2010.
Actieve functies van Eyal Kalo
| Bedrijven | Functie | Begin |
|---|---|---|
| ESENSE-LAB LTD | Hoofd Techniek/Wetenschap/O&O | - |
| INNOCAN PHARMA CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-05-2023 |
Opleiding van Eyal Kalo
| Weizmann Institute of Science | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| INNOCAN PHARMA CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
eSense-Lab Ltd.
 eSense-Lab Ltd. BiotechnologyHealth Technology eSense-Lab Ltd. engages in the research and development of terpene technology. It focuses on the creation of virtual plants through the reverse engineering of plants, and reconstruction of their essence using alternate natural products. It also specializes in the commercialization of the phytochemical profiling of plants, and combines genetics, messenger RNA (mRNA), protein expression, and phytochemical profiles to generate a model of targeted plants. The company was founded on April 13, 2016 and is headquartered in Ness Ziona, Israel. | Health Technology |
